<< Read Full Article
<< Read Full Article
Updated from 11:47 a.m. EST Shares of Mylan (MYL Quote) were on the rise Tuesday morning after the drugmaker said it had started selling a generic version of Bristol-Myers Squibb's (BMY Quote) HIV drug Zerit.
Matrix Laboratories, an Indian company owned in large part by Mylan, received final approval Monday from the Food and Drug Administration for stavudine capsules in 15, 20, 30 and 40 mg doses, Mylan said.
The product was shipped immediately under the Mylan Pharmaceutical Inc. label, Mylan said.
Mylan shares ended Tuesday's trading session up 17 cents, or 1.8%, to $9.68. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet